DECAPEPTYL L.P. 11.25 mg, powder and solvent for injectable suspension (IM or SC) form with extended release over 3 months bottle, 4 ml
Active ingredients: Triptorelin pamoate, Triptorelin
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for injectable suspension with extended releasebottle, 4 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DECAPEPTYL L.P. 11,25 mg, poudre et solvant pour suspension injectable (IM ou SC) forme à libération prolongée sur 3 mois
- Pharmaceutical form
- poudre et solvant pour suspension injectable à libération prolongée
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 4 ml - 1 ampoule(s) en verre de 2 ml avec seringue(s) avec aiguille(s)
- Marketing authorisation holder
- PHARMA LAB
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Apr 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60828074CIP74900510CIP133400949005109Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TRIPTORÉLINEpoudre | 11,25 mg · une unité de prise | FT |
| PAMOATE DE TRIPTORÉLINEpoudre | 15 mg · une unité de prise | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.